188 related articles for article (PubMed ID: 36994064)
1. Trends of rhino-orbito-cerebral mucormycosis in COVID-19 patients: An observational study.
Singh N; Singh S; Singh P; Mishra N; Sinha BP; Shrama AK
J Family Med Prim Care; 2022 Dec; 11(12):7891-7896. PubMed ID: 36994064
[TBL] [Abstract][Full Text] [Related]
2. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
[TBL] [Abstract][Full Text] [Related]
3. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.
Raj A; Nishant P; Sadhukhan K; Saha BC; Sinha U; Kokkayil P; Gupta A; Kumar A; Tiwari P
Indian J Ophthalmol; 2023 Jan; 71(1):249-256. PubMed ID: 36588245
[TBL] [Abstract][Full Text] [Related]
5. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
[TBL] [Abstract][Full Text] [Related]
6. A Cross-Sectional Study of First Hundred Cases of Rhino-Orbital-Cerebral Mucormycosis Admitted at a Tertiary Care Hospital.
Poswal L; Bunkar GL; Sharma R; Jain A; Samar N; Mathur N; Singh M; Kaushik PB
Indian J Community Med; 2022; 47(3):433-436. PubMed ID: 36438531
[TBL] [Abstract][Full Text] [Related]
7. Perioperative anesthesia challenges and outcomes of patients with Rhino-Orbito-Cerebral Mucormycosis during the second wave of COVID-19 pandemic: An observational study.
Kumari K; Rathod D; Meshram T; Mohammed S; Raju S; Sharma A; Chaudhary B; Bhatia P
J Anaesthesiol Clin Pharmacol; 2023; 39(4):615-621. PubMed ID: 38269163
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
9. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
[TBL] [Abstract][Full Text] [Related]
10. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
11. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
12. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
[TBL] [Abstract][Full Text] [Related]
13. Rhino-Orbito-Cerebral Mucormycosis: An Audit.
Saravanam PK; Thattarakkal VR; Arun A
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2686-2692. PubMed ID: 36452555
[TBL] [Abstract][Full Text] [Related]
14. Hit or Miss: The Dilemma of Specimen Selection for Microbiological Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis (ROCM-CAM).
Jain V; Aggarwal A; Shrimali T; Vishwakarma K; Paul D; Kombade SP; Sharma V; Soni K; Choudhary B; Goyal A; Chugh A; Tiwari S; Sharma DK; Agarwal A; Misra S
Infect Disord Drug Targets; 2023; 23(1):e160822207524. PubMed ID: 35975857
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting clinical outcome in COVID-associated rhino-orbito-cerebral mucormycosis (CAROM) patients-An ambispective, single-arm, observational study.
Singh A; Goel G; Khan M; Kanodia A; Sikka K; Thakar A
Am J Otolaryngol; 2023; 44(6):103975. PubMed ID: 37478538
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab.
Singh P; Kaur K; Jindal V; Kaur M; Kaur M; Singh N
J Family Med Prim Care; 2022 Dec; 11(12):7788-7794. PubMed ID: 36994047
[TBL] [Abstract][Full Text] [Related]
17. Radiological Manifestations of Rhino-Orbito-Cranial Mucormycosis in COVID-19 Patients Correlated With Pathological and Clinical Outcomes and Emphasis on Magnetic Resonance Imaging-Based Scoring System.
Patil C; Kumar A; Battula V; Kumar P; Kollu R; Kotamraju S; Nethi Balingari BL; Reddy S; Ravula S; Reddy AR
Cureus; 2023 Mar; 15(3):e35745. PubMed ID: 37020477
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated mucormycosis in India: Why such an outbreak?
Pasquier G
J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
[TBL] [Abstract][Full Text] [Related]
20. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
Kumar S; Kumar H; Mali M; Meena BL
Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]